Director of urology outpatient services at th VA hospital in Atlanta, Ga
Urology
Dr. Donald P. Finnerty, MD
Doctor Donald P. Finnerty, MD is an expert in the field of Urology. He studied medicine at Georgetown University School of Medicine. Georgetown University School of Medicine has a rank of 49 in research and a 84 in primary care He received awards:"Fellow (FACS)". He accepts all Medicare patients.
Schools
Georgetown University School Of Medicine
Vanderbilt University
Emory University
Procedures Preformed
- Cystometry
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- Excision of Testicular Lesion
- Lithotripsy
- View All
Conditions Treated
- Balanoposthitis
- Bladder Cancer
- Bladder Infection
- Blood in Urine (Hematuria)
- View All
Doctors Specialties
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Assurant Health
- Bakery & Confectionary Union Plan
- Blue Card PPO
- Blue Choice HMO
- Blue Choice Option POS
- Blue Open Access POS
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Golden Rule
- GEHA
- Choice Care PPO
- Preferred PPO
- Medicaid
- Medical Mutual of Ohio
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- WellCare
Awards
Education
-
Vanderbilt University
-
Georgetown University School of Medicine
Drug Facts
NPI NUMBER |
|
1780667329 |
NPPES Provider LastName |
|
FINNERTY |
NPPES Provider FirstName |
|
DONALD |
NPPES Provider ZIPCode |
|
302651931 |
NPPES Provider State |
|
GA |
Specialty Description |
|
Urology |
Total Claim Count |
|
1245.0 |
Distinct Opioid Count |
|
2.0 |
Opioid Claim Count |
|
25.0 |
Percent Opioid Claims |
|
2.01 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1780667329 |
Last Name Of The Provider |
FINNERTY |
First Name Of The Provider |
DONALD |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog